TrueHealth Medical lands on HKEX as the first Hong Kong-listed percutaneous surgical robotics player, with a 216.96% debut rally

DagangNews· July 2, 2026

TrueHealth Medical has officially debuted on the Hong Kong Stock Exchange, marking its entry as the first percutaneous surgical robotics company to list in the territory. The company's stock witnessed a remarkable 216.96% rally during its market debut, signaling intense investor interest in the high-growth surgical robotics segment. This successful initial public offering underscores the increasing valuation and strategic importance of specialized medical device firms within the global healthcare technology landscape.

Read the full story at DagangNews

Summary generated by RabbitReport AI from public reporting. The full article and original reporting belong to DagangNews.

More in Medical Devices

CMS and FDA Unveil RAPID Pathway to Accelerate Medicare Coverage for Breakthrough Devices

The Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) have launched the Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway to streamline the transition from regulatory authorization to reimbursement. This initiative aims to reduce the coverage gap for designated Class II and Class III breakthrough medical devices from over a year to as little as two months. By aligning evidence requirements between the two agencies, the program seeks to provide Medicare beneficiaries with faster access to life-saving technologies while reducing administrative hurdles for manufacturers.

July 3, 2026

WHX Bangkok 2026 and Medtec Southeast Asia to Showcase Thailand as Regional MedTech Hub

Thailand is set to host the World Health Expo (WHX) Bangkok and Medtec Southeast Asia 2026, a twin exhibition event aimed at reinforcing the country's position as a healthcare innovation and medical manufacturing hub. Organized by Informa Markets, the event will feature over 950 exhibitors and highlight significant advancements in artificial intelligence, diagnostics, and healthcare manufacturing. This gathering is critical for the medical device sector as the Southeast Asian market is projected to reach US$18.6 billion by 2029, driven by rapid growth in regional supply chains and technological integration.

July 3, 2026

Fisher & Paykel Healthcare Highlights Respiratory Care Portfolio Amid Global Demand

Fisher & Paykel Healthcare is prioritizing its respiratory care portfolio to meet sustained global demand for ventilation and oxygen therapy solutions in both hospital and home settings. The company is leveraging a dual-revenue model that combines capital equipment sales with recurring revenue from high-volume consumables like breathing circuits and patient interfaces. This strategic focus is driven by aging demographics and increased clinical investment in critical-care capacity, positioning the firm for long-term growth through international expansion and continuous research and development.

July 2, 2026

In Korea, the 'big brother' should come out quickly in the medical device field

The South Korean medical device industry is facing a critical juncture where the emergence of a dominant leading company is seen as essential for global competitiveness. Industry observers suggest that a 'big brother' figure must appear within the next two to three years to anchor the domestic market and drive innovation. This development is considered vital for the structural maturity and long-term success of the nation's medical technology sector.

July 1, 2026